Literature DB >> 12850274

Genomic organization, chromosomal localization and adipocytic expression of the murine gene for CORS-26 (collagenous repeat-containing sequence of 26 kDa protein).

A Schäffler1, A Ehling, E Neumann, H Herfarth, I Tarner, S Gay, J Schölmerich, U Müller-Ladner.   

Abstract

The murine gene for CORS-26 shows striking homologies to the adipocyte-specific secretory protein adiponectin (belonging to the newly discovered C1q/TNF molecular superfamily) and its expression has been reported to be restricted to fibroblasts, cartilage and kidney. However, the present data demonstrate specific induction of CORS-26 mRNA expression in hormonally differentiated 3T3-L1 adipocytes, but not in preadipocytes. Furthermore, CORS-26 mRNA expression could be demonstrated in human synovial adipocytes of the knee by in situ hybridization. Since the genes for CORS-26 and adiponectin are homologous for their COOH-terminal globular domain and of their N-terminal collagenous domain, they might have originated by divergence from an innate mesenchymal precursor molecule directing the development of myocytes, adipocytes and chondrocytes from a mesenchymal stem cell. Here, the complete genomic organization with exon/intron boundaries together with exon-specific primer combinations are presented. Additionally, approximately 1 kb of the TATA-box-containing promoter region was cloned and analyzed for putative transcription factor binding sites. The chromosomal localization of the murine CORS-26 gene was mapped to mouse chromosome 15 A2 by fluorescence in situ hybridization (FISH). Since the linkage loci for proteoglycan-induced arthritis and MRL/lpr arthritis in mice have been mapped to that chromosomal region, CORS-26 might represent the underlying mechanism of disease. The present data provide the basis for further investigation of the CORS-26 gene regulation in the context of mesenchymal tissue development, chondrocyte/adipocyte function and bone or skeletal disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12850274     DOI: 10.1016/s0167-4781(03)00114-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Regulation of the transcriptional activation of CTRP3 in chondrocytes by c-Jun.

Authors:  Mi-Jin Kim; Eun-Ju Park; Wan Lee; Jung-Eun Kim; Seung-Yoon Park
Journal:  Mol Cell Biochem       Date:  2012-05-30       Impact factor: 3.396

Review 2.  C1q/TNF-Related Protein 3 (CTRP3) Function and Regulation.

Authors:  Ying Li; Gary L Wright; Jonathan M Peterson
Journal:  Compr Physiol       Date:  2017-06-18       Impact factor: 9.090

3.  CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.

Authors:  Dan Wu; Hong Lei; Jin-Yu Wang; Cheng-Lin Zhang; Han Feng; Feng-Ying Fu; Li Li; Li-Ling Wu
Journal:  J Mol Med (Berl)       Date:  2015-07-03       Impact factor: 4.599

4.  Molecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions.

Authors:  G William Wong; Sarah A Krawczyk; Claire Kitidis-Mitrokostas; Tracy Revett; Ruth Gimeno; Harvey F Lodish
Journal:  Biochem J       Date:  2008-12-01       Impact factor: 3.857

Review 5.  Metabolic function of the CTRP family of hormones.

Authors:  Marcus M Seldin; Stefanie Y Tan; G William Wong
Journal:  Rev Endocr Metab Disord       Date:  2014-06       Impact factor: 6.514

6.  Target genes of myostatin loss-of-function in muscles of late bovine fetuses.

Authors:  Isabelle Cassar-Malek; Florent Passelaigue; Carine Bernard; Jean Léger; Jean-François Hocquette
Journal:  BMC Genomics       Date:  2007-03-01       Impact factor: 3.969

Review 7.  New Insights Into Implications of CTRP3 in Obesity, Metabolic Dysfunction, and Cardiovascular Diseases: Potential of Therapeutic Interventions.

Authors:  Bei Guo; Tongtian Zhuang; Feng Xu; Xiao Lin; Fuxingzi Li; Su-Kang Shan; Feng Wu; Jia-Yu Zhong; Yi Wang; Ming-Hui Zheng; Qiu-Shuang Xu; Ullah Muhammad Hasnain Ehsan; Ling-Qing Yuan
Journal:  Front Physiol       Date:  2020-12-03       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.